European Society for Medical Oncology (ESMO)

Professor Ben Solomon reports on key results from ESMO Congress 2023 on LBA2 - ALINA: efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK+ non-small cell lung cancer (NSCLC)
https://www.youtube.com/watch?v=pQoJJ...

1 year ago | [YT] | 0